⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5417771 | 0.78 | FAAH (0.41) | — | |
| SCHEMBL3622707 | 0.75 | FAAH (0.43) | — | |
| SCHEMBL5522225 | 0.75 | FAAH (0.43) | — | |
| SCHEMBL5466852 | 0.73 | RAB9A (0.40) | — | |
| SCHEMBL5513719 | 0.73 | RAB9A (0.40) | — | |
| SCHEMBL5420085 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL5461922 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL5945966 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL5945917 | 0.69 | PKM (0.44) | — | |
| SCHEMBL5460211 | 0.69 | PKM (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070049594-A1 | Novel compounds and compositions as cathepsin inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2007-03-01 | — | — | US | disclosed |
| US-20040142999-A1 | Novel compounds and compositions as cathepsin inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2004-07-22 | — | — | US | disclosed |